These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6761392)

  • 1. Epidemiologic profile of streptococcal infections in collectivities of children followed over a sixteen year period.
    Măgureanu E; Dobrescu A; Horhogea G; Ulmeanu V; Grigoriu T; Debeleac L; Ionescu M; Ionescu E; Zolotovschi JC
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):375-84. PubMed ID: 6761392
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular epidemiology of the sil streptococcal invasive locus in group A streptococci causing invasive infections in French children.
    Bidet P; Courroux C; Salgueiro C; Carol A; Mariani-Kurkdjian P; Bonacorsi S; Bingen E
    J Clin Microbiol; 2007 Jun; 45(6):2002-4. PubMed ID: 17376880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    Trans Assoc Am Physicians; 1988; 101():88-92. PubMed ID: 3077732
    [No Abstract]   [Full Text] [Related]  

  • 4. The genetic properties of Streptococcus pyogenes emm49 genotype strains recently emerged among severe invasive infections in Japan.
    Ikebe T; Endo M; Ueda Y; Okada K; Suzuki R; Minami T; Tanaka H; Nakanishi N; Tomita M; Nishie H; Ishii N; Sasaki E; Miura Y; Yamamura T; Watanabe H
    Jpn J Infect Dis; 2004 Aug; 57(4):187-8. PubMed ID: 15329456
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system.
    Wahl RU; Lütticken R; Stanzel S; van der Linden M; Reinert RR
    Clin Microbiol Infect; 2007 Dec; 13(12):1173-8. PubMed ID: 17850344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Further study of the prevention of streptococcal infections in experiments on monkeys].
    Keller V; Dzhikidze EK; Voskanian NA; Kiunemund O; Knol' G
    Vestn Akad Med Nauk SSSR; 1986; (3):66-8. PubMed ID: 3518270
    [No Abstract]   [Full Text] [Related]  

  • 7. Outbreak of invasive group A streptococcal disease among children attending a day-care center.
    Aguero J; Ortega-Mendi M; Eliecer Cano M; Gonzalez de Aledo A; Calvo J; Viloria L; Mellado P; Pelayo T; Fernandez-Rodriguez A; Martinez-Martinez L
    Pediatr Infect Dis J; 2008 Jul; 27(7):602-4. PubMed ID: 18520444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rheumatic fever].
    Fujikawa S
    Ryoikibetsu Shokogun Shirizu; 2000; (31):454-7. PubMed ID: 11269134
    [No Abstract]   [Full Text] [Related]  

  • 9. [Streptococcal infections in childhood. Evaluation of immunologic response].
    Colli R; Frigerio G; Bianchi G
    Minerva Pediatr; 1985 Nov; 37(21-22):865-74. PubMed ID: 3912658
    [No Abstract]   [Full Text] [Related]  

  • 10. Superantigens and streptococcal toxic shock syndrome.
    Proft T; Sriskandan S; Yang L; Fraser JD
    Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of streptococcal infections in childrens collectives in Bucarest, in the period 1963-1966].
    Ivan IM; Mihalcou F; Horhogea G; Tisu A; Ionesco G; Katona E; Debeleac L
    Arch Roum Pathol Exp Microbiol; 1967 Sep; 26(3):627-42. PubMed ID: 4873550
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-M protein antibody in post-streptococcal reactive arthritis.
    Maeno N; Yoshinaga M; Takei S; Nishi J; Imanaka H; Wahid MR; Sameshima K; Miyata K
    J Rheumatol; 1999 Jun; 26(6):1417-9. PubMed ID: 10381072
    [No Abstract]   [Full Text] [Related]  

  • 13. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
    Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
    Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary prevention of rheumatism: the status and outlook (vaccine)].
    Rotta Y
    Ter Arkh; 1985; 57(11):97-100. PubMed ID: 3909476
    [No Abstract]   [Full Text] [Related]  

  • 15. Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study.
    Ekelund K; Darenberg J; Norrby-Teglund A; Hoffmann S; Bang D; Skinhøj P; Konradsen HB
    J Clin Microbiol; 2005 Jul; 43(7):3101-9. PubMed ID: 16000420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group A streptococcus epidemiology and vaccine implications.
    Cohen-Poradosu R; Kasper DL
    Clin Infect Dis; 2007 Oct; 45(7):863-5. PubMed ID: 17806050
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunity to group a streptococcal M proteins: forging a single-edged sword.
    Madoff LC
    Clin Infect Dis; 2005 Oct; 41(8):1123-4. PubMed ID: 16163630
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epidemiological study of streptococcal infections in groups of children. Prospective survey over a period of 8 years].
    Mihalcu F; Horhogea G; Debeleac L; Florea V; Tisu A; Anghelescu P; Croitorescu M; Van Saanen P
    Arch Roum Pathol Exp Microbiol; 1973 Mar; 32(1):107-20. PubMed ID: 4755164
    [No Abstract]   [Full Text] [Related]  

  • 19. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies.
    Mascini EM; Jansze M; Schellekens JF; Musser JM; Faber JA; Verhoef-Verhage LA; Schouls L; van Leeuwen WJ; Verhoef J; van Dijk H
    J Infect Dis; 2000 Feb; 181(2):631-8. PubMed ID: 10669348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing epidemiology of acute rheumatic fever in the United States.
    Lee GM; Wessels MR
    Clin Infect Dis; 2006 Feb; 42(4):448-50. PubMed ID: 16421786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.